147 related articles for article (PubMed ID: 2525471)
1. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Dauvois S; Spinola PG; Labrie F
Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Li S; Lévesque C; Geng CS; Yan X; Labrie F
Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
[TBL] [Abstract][Full Text] [Related]
3. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
4. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Luo S; Stojanovic M; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
[TBL] [Abstract][Full Text] [Related]
6. Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats.
Zaccheo T; Casazza AM; di Salle E; Pollini C; di Marco A
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1193-7. PubMed ID: 6236980
[TBL] [Abstract][Full Text] [Related]
7. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
8. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
Ishikawa H; Iino Y; Izuo M; Takikawa H
Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
[TBL] [Abstract][Full Text] [Related]
9. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
Oikawa T; Hiragun A; Yoshida Y; Ashino-Fuse H; Tominaga T; Iwaguchi T
Cancer Lett; 1988 Dec; 43(1-2):85-92. PubMed ID: 2462464
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivo.
Kangas L; Grönroos M
J Steroid Biochem; 1990 Jun; 36(3):253-7. PubMed ID: 2142248
[TBL] [Abstract][Full Text] [Related]
12. Additive effects of medroxyprogesterone acetate and 5-fluorouracil derivative on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Sakamoto S; Hara Y; Mitamura T; Sassa S; Kudo H; Suzuki S; Kuwa K; Okayasu I; Shinoda H
Anticancer Drugs; 1998 Apr; 9(4):351-7. PubMed ID: 9635926
[TBL] [Abstract][Full Text] [Related]
13. [Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
Iino Y; Yamazaki K; Ishikawa H; Endo K; Arai T; Ogawa T; Hoshino K; Ishida T; Yokoe T; Takahashi T
Gan No Rinsho; 1984 Oct; 30(13):1633-7. PubMed ID: 6239934
[TBL] [Abstract][Full Text] [Related]
14. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Waseda N; Kato Y; Matsushita N; Imura H
Endocrinol Jpn; 1983 Aug; 30(4):529-35. PubMed ID: 6323151
[TBL] [Abstract][Full Text] [Related]
15. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
Nomura S; Yoshida H; Kaneko Y
In Vivo; 1990; 4(2):121-5. PubMed ID: 1966585
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.
Di Carlo F; Conti G; Giubertoni M; Muccioli G; Racca S
Cancer Chemother Pharmacol; 1991; 27(4):271-7. PubMed ID: 1825621
[TBL] [Abstract][Full Text] [Related]
17. Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
Iino Y; Ogawa T; Yoshida M; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1990 Sep; 20(3):259-62. PubMed ID: 2147726
[TBL] [Abstract][Full Text] [Related]
18. Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors.
Racca S; Conti G; Crispino A; Gallo E; Di Carlo F
Chemioterapia; 1985 Jun; 4(3):236-8. PubMed ID: 3928182
[TBL] [Abstract][Full Text] [Related]
19. [Effect of medroxyprogesterone acetate (MAP) and vitamin C on DMBA induced rat mammary cancer in relation to estrogen receptor(ER)].
Iino Y; Yamazaki K; Ogawa T; Hirai T; Arai T; Ishikawa H; Endo K; Kawai T; Izuo M; Takikawa H
Gan No Rinsho; 1983 Aug; 29(9):949-54. PubMed ID: 6225884
[TBL] [Abstract][Full Text] [Related]
20. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
